- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Ascendis Pharma
Market Cap: US$15.1b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$245.38
7D
-1.3%
1Y
52.3%
Madrigal Pharmaceuticals
Market Cap: US$12.2b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$527.11
7D
0.3%
1Y
78.7%
Insmed
Market Cap: US$31.2b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$142.82
7D
-5.5%
1Y
105.5%
Ionis Pharmaceuticals
Market Cap: US$12.5b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$74.87
7D
-0.1%
1Y
162.6%
Alnylam Pharmaceuticals
Market Cap: US$41.1b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$310.94
7D
-6.6%
1Y
33.6%
BeOne Medicines
Market Cap: US$35.9b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$318.07
7D
4.1%
1Y
38.8%
BridgeBio Pharma
Market Cap: US$14.9b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$76.68
7D
-1.5%
1Y
128.8%
AbbVie
Market Cap: US$368.6b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$203.71
7D
-1.3%
1Y
19.7%
Jazz Pharmaceuticals
Market Cap: US$12.5b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$202.56
7D
3.7%
1Y
101.9%
Eli Lilly
Market Cap: US$829.5b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$919.90
7D
-1.0%
1Y
12.5%
Natera
Market Cap: US$29.5b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$207.74
7D
2.9%
1Y
46.1%
Viatris
Market Cap: US$17.1b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$14.87
7D
7.5%
1Y
96.4%
Royalty Pharma
Market Cap: US$29.6b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$49.30
7D
1.8%
1Y
53.2%
Elanco Animal Health
Market Cap: US$11.8b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.68
7D
-0.8%
1Y
179.2%
Revvity
Market Cap: US$10.5b
Provides health sciences solutions, technologies, and services.
RVTY
US$93.03
7D
0.4%
1Y
3.6%
Waters
Market Cap: US$32.2b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$335.61
7D
3.4%
1Y
6.1%
BioMarin Pharmaceutical
Market Cap: US$10.5b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$54.88
7D
0%
1Y
-6.4%